Sign in

Private company

Provention Bio, Inc.

Provention Bio, Inc. is an American pharmaceutical preparations company based in Lebanon.2

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersLebanon, United States2
  • Incorporated inDE3
  • Business address55 Broad Street, 2Nd Floor, Red Bank, Nj 077013
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI5493003LM26XAVJKLD342
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 61725932

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-993.9%Operating margin4
-880.7%Net margin4
824.4%Revenue growth, 20224
-93.2%Return on equity4
0.19×Debt to equity4
-$76.2MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development49¢$75.8M
  • Selling, general and admin42¢$64.1M
  • Interest1¢$1.0M
  • Income tax9¢$13.4M

Out of $12.9M in revenue.4 The company lost money this year.

Financial statements

Revenue4$12.9M in 2022+824% since 2021
0$5.0M$10.0M$15.0M2021: $1.4M$1.4M20212022: $12.9M$12.9M2022+824%
Operating income5674-$128.2M in 2022+1302% since 2017
-$150.0M-$100.0M-$50.0M02017: -$9.1M-$9.1M20172018: -$26.8M-$26.8M2018+193%2019: -$44.4M-$44.4M2019+65%2020: -$99.7M-$99.7M2020+125%2021: -$115.6M-$115.6M2021+16%2022: -$128.2M-$128.2M2022+11%
Net income5674-$113.6M in 2022+1143% since 2017
-$150.0M-$100.0M-$50.0M02017: -$9.1M-$9.1M20172018: -$26.5M-$26.5M2018+190%2019: -$43.3M-$43.3M2019+63%2020: -$98.6M-$98.6M2020+128%2021: -$114.4M-$114.4M2021+16%2022: -$113.6M-$113.6M2022−1%
Fiscal year2016201720182019202020212022
Revenue$1.4M4$12.9M4
Research and development$7.7M5$22.6M6$36.4M7$66.4M4$69.6M4$75.8M4
Selling, general and admin$33.3M4$47.3M4$64.1M4
Operating expenses$117.0M4$141.1M4
Operating income-$9.1M5-$26.8M6-$44.4M7-$99.7M4-$115.6M4-$128.2M4
Interest$1.0M4
Income before tax-$115.4M4-$127.0M4
Income tax-$187.0K6-$523.0K4-$1.0M4-$13.4M4
Net income-$9.1M5-$26.5M6-$43.3M7-$98.6M4-$114.4M4-$113.6M4
Earnings per share-$1.884-$1.814-$1.524
Shares (weighted, basic)63.1M shares474.7M shares4

Compare Provention Bio, Inc. with another company

Corporate structure

Provention Bio, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Provention Bio, Inc.

  • Provention Bio, Inc. Lebanon, New Jersey, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Provention Bio, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$3.2M4 Dec 31, 2022$2.4M4 Dec 31, 2021+32.7%
Accumulated depreciation$1.0M4 Dec 31, 2022$420.0K4 Dec 31, 2021+143.1%
Property and equipment, net$2.2M4 Dec 31, 2022$2.0M4 Dec 31, 2021+9.6%
Operating-lease assets (leased space)$321.0K4 Dec 31, 2022$373.0K4 Dec 31, 2021−13.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$44.0M4 Dec 31, 2022$78.2M4 Dec 31, 2021−43.7%
Marketable securities, current$121.0M4 Dec 31, 2022$16.9M4 Dec 31, 2021+614.9%
Marketable securities, non-current$32.0M4 Dec 31, 2021
Debt securities available for sale$48.9M7 Dec 31, 2021$19.5M7 Dec 31, 2020+150.6%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, net$59.6M4 Dec 31, 2022

Inventory

ItemLatestA year beforeChange
Inventory, total$1.2M4 Dec 31, 2022
Work in process$1.1M4 Dec 31, 2022
Finished goods$91.0K4 Dec 31, 2022

Leadership

Who has led Provention Bio, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Ashleigh Palmer2018–2023

President

  1. Ashleigh Palmer2018–2020

Chief financial officer

  1. Andrew T. Drechsler2018–2021
  2. Thierry Chauche2021–2023

Chief operating officer

  1. Eleanor Ramos2018–2019
20202025
Board members and other officers (17)

Timeline

  1. Apr 27, 20238-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer32
  2. Mar 24, 20238-K Financial statements and exhibits33
  3. Mar 13, 20238-K Entered a material agreement; Executive or director change; Bylaws or fiscal year changed34
  4. Feb 16, 20238-K Executive or director change35
  5. Feb 13, 20238-K Unregistered sale of shares; Regulation FD disclosure36
  6. Feb 2, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares37
  7. Jan 5, 20238-K Executive or director change; Regulation FD disclosure38
  8. Dec 6, 20228-K Other events39
  9. Nov 18, 20228-K Regulation FD disclosure; Other events40
  10. Nov 3, 20228-K Results of operations41
  11. Oct 6, 20228-K Entered a material agreement; Regulation FD disclosure42
  12. Aug 31, 20228-K Entered a material agreement; New debt or obligation; Unregistered sale of shares43
  13. Jul 3, 2018New chief executive Ashleigh Palmer becomes CEO12

Calendar

When it reported results

  1. Nov 3, 2022Reported quarterly or annual results41
  2. Aug 4, 2022Reported quarterly or annual results44
  3. May 5, 2022Reported quarterly or annual results45
  4. Feb 24, 2022Reported quarterly or annual results46
  5. Nov 4, 2021Reported quarterly or annual results47

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

158 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 24 major events, 81 insider forms, 12 large holders, 35 other. The latest 20:

  1. May 8, 202315-12G EDGAR
  2. Apr 28, 2023EFFECT EDGAR
  3. Apr 28, 2023EFFECT EDGAR
  4. Apr 28, 2023EFFECT EDGAR
  5. Apr 28, 2023SC 13G/A EDGAR
  6. Apr 28, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Apr 27, 20234 EDGAR
  8. Apr 27, 20234 EDGAR
  9. Apr 27, 20234 EDGAR
  10. Apr 27, 20234 EDGAR
  11. Apr 27, 20234 EDGAR
  12. Apr 27, 20234 EDGAR
  13. Apr 27, 20234 EDGAR
  14. Apr 27, 20234 EDGAR
  15. Apr 27, 20234 EDGAR
  16. Apr 27, 20234 EDGAR
  17. Apr 27, 20234 EDGAR
  18. Apr 27, 20234 EDGAR
  19. Apr 27, 20234 EDGAR
  20. Apr 27, 20234 EDGAR

The 158 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

16 open-market trades by officers, directors and large owners since October 2021: 3 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 14, 2023Sessa Capital IM GP, LLC10% ownerSale2,190,549$24.32$53.3MForm 4
Feb 13, 2023Leon FranciscoChief Scientific OfficerSale25,985$10.04$260.9KForm 4
Feb 13, 2023Palmer AshleighDirector and CEOSale25,835$10.04$259.4KForm 4
Feb 10, 2023Leon FranciscoChief Scientific OfficerSale50,000$10.11$505.5KForm 4
Feb 10, 2023Hoitt JasonChief Commercial OfficerSale4,500$10.00$45.0KForm 4
Feb 10, 2023Palmer AshleighDirector and CEOSale50,000$10.11$505.5KForm 4
Jan 18, 2023Palmer AshleighDirector and CEOSale24,165$10.27$248.2KForm 4
Jan 18, 2023Leon FranciscoChief Scientific OfficerSale24,015$10.27$246.6KForm 4
Jan 18, 2023Sessa Capital (Master), L.P.10% ownerSale3,000,000$9.40$28.2MForm 4
Dec 29, 2022Leon FranciscoChief Scientific OfficerSale187,000$10.26$1.9MForm 4
Dec 27, 2022Leon FranciscoChief Scientific OfficerSale10,674$10.00$106.7KForm 4
Dec 23, 2022Leon FranciscoChief Scientific OfficerSale375$10.00$3.8KForm 4
Dec 22, 2022Leon FranciscoChief Scientific OfficerSale1,568$10.00$15.7KForm 4
Dec 3, 2021Ramos EleanorChief Medical OfficerBuy5,201$6.49$33.8KForm 4
Nov 30, 2021Palmer AshleighDirector and CEOBuy3,750$6.66$25.0KForm 4
Nov 24, 2021Leon FranciscoChief Scientific OfficerBuy5,550$7.24$40.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Provention Bio, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARProvention Bio, Inc.1
  • CIK0001695357
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address55 Broad Street, 2Nd Floor, Red Bank, NJ 077011
  • Phone908-428-91361
  • Shares outstanding94,780,874 as of Mar 20, 20234
  • Public float$244.7M as of Jun 30, 20224
  • On EDGAR sinceMay 4, 20171
  • Filings426 in all: 4 (166), 8-K (61), 3 (26), SC 13G/A (20), 10-Q (14), CORRESP (13), SC 13G (13), UPLOAD (10)1
    All 49 form types

    424B5 (8), S-8 (8), S-8 POS (8), EFFECT (7), S-1/A (6), 10-K (5), DEFA14A (5), DEF 14A (4), POS AM (4), SC 14D9/A (4), SC 13D/A (3), SC TO-T/A (3), 10-K/A (2), 424B1 (2), 424B3 (2), 8-K/A (2), CT ORDER (2), DRS (2), S-1 (2), S-3 (2), SC TO-C (2), 10-Q/A (1), 15-12G (1), 25-NSE (1), 4/A (1), 5 (1), 8-A12B (1), CERT (1), D (1), FWP (1), POSASR (1), PRE 14A (1), RW (1), S-1MEF (1), S-3/A (1), S-3ASR (1), S-3MEF (1), SC 13D (1), SC 14D9 (1), SC TO-T (1), SC14D9C (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2023
    Quarterly report (10-Q) Nov 3, 2022
    Proxy statement (DEF 14A) Apr 5, 2022
    Latest 8-K (8-K) Apr 27, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
    SEC EDGAROther events
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52